[XLS] Baseline characteristics of the 621 patients with multidrug/rifampin ...,https://synapse.koreamed.org/articles/Table.php%3Fxn%3Djkms-35-e284%26jc%3D0063jkms%26id%3DT1-jkms-35-e284%26mode%3Dexport
[XLS] Concentrations of antibiotic combinations that exerted synergistic ...,https://synapse.koreamed.org/articles/Table.php%3Fxn%3Dalm-36-138%26jc%3D3039alm%26id%3DT4-alm-36-138%26mode%3Dexport
[XLS] The Korean Journal of Internal Medicine,https://www.kjim.org/journal/Table.php%3Fxn%3Dkjim-19-4-261-9.xml%26id%3D%26mode%3Dexport
[XLS] Publisher DOI Year Volume Issue Page Title Author(s) Link Clinical ...,https://www.e-ce.org/journal/crossRefTDM.php%3Fnumber%3D6347%26export%3Dexcel
"[XLS] Table 1. Results of sequential acid-fast smear, mycobacterial culture ...",https://www.ekjm.org/journal/Table.php%3Fid%3Dt1-kjm-82-5-614-16%26mode%3Dexport
[XLS] Table 2. Treatment regimen for nontuberculous mycobacterial lung ...,https://www.ekjm.org/journal/Table.php%3Fid%3Dt2-kjm-82-3-274-4%26mode%3Dexport
[XLS] Chemical A B C D E F G H I J 1 2 3 Population Affected By Incident ...,https://nmpoisoncenter.unm.edu/common/docs/calculating_chemical_biological_antidotes.xls
[XLS] Sheet1 A B C D E F G H I J K L 1 Sample Form to Monitor Toxicity ...,https://www.currytbcenter.ucsf.edu/sites/default/files/sampleform-to-monitor-toxicity-rif_7-26-18.xls
[XLS] ic-51-355-s003,https://icjournal.org/DownloadSupplMaterial.php%3Fid%3D10.3947/ic.2019.51.4.355%26fn%3Dic-51-355-s003.xls
[XLS] Sheet1,https://www.iatp.org/sites/default/files/Antibiotic_Resistance_and_Genetically_Engineer.xls
